Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZWT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,163
Award facts
- Contract value 100% obligated
- $34,162.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,162.86 delivery order to AmerisourceBergen Drug Corp (via parent company Cencora, Inc.) on January 28, 2026, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) injectable medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of January 29, 2026. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's headquarters location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The parent company Cencora, Inc. holds an even larger Indefinite Delivery Contract with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2031, enabling the supply of a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military treatment facilities and government healthcare institutions globally. The award of this specific delivery order for Ozempic, a diabetes medication commonly used in military medical supply chains, demonstrates AmerisourceBergen's continued capability to fulfill federal pharmaceutical procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F4ZWT?
SPE2DR26F4ZWT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F4ZWT worth?
The government has obligated $34,163 on SPE2DR26F4ZWT.
Is contract SPE2DR26F4ZWT an order under another contract?
Yes. SPE2DR26F4ZWT is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZWT competed?
The extent of competition for SPE2DR26F4ZWT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award